KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is an open-label, phase II study of KN046 combined with chemotherapy and palliative
radiotherapy in patients with recurrent or metastatic esophageal squamous cell carcinoma to
evaluate the safety, efficacy and tolerance.
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Chest Hospital
Collaborators:
First Affiliated Hospital of Suzhou Medical College The First Affiliated Hospital of Suzhou University